Table 1 The comparisons of knowledge and perception between the examinees and non-examinees and between the subjects and non-subjects
Subjects | Non-subjects | |||
|---|---|---|---|---|
Alla | Examinees | Non-examinees | ||
n | 297 | 170 | 102 | 289 |
Age, mean, SD | 19.2, 3.3** | 18.0, 2.1* | 21.9, 4.0* | 25.6, 5.0** |
Sex, male/female | 142/155 | 79/91 | 50/52 | 132/157 |
Knowledge of the meaning of TUE (%), Yes, No | 59.5, 40.5 | 65.5, 34.5 | 54.9, 45.1 | - |
Knowledge of existence of benefits and harms in TUE, n (%) | 49 (16.5) | 25 (14.9) | 23 (23.0) | 40 (13.8) |
Knowledge of the IARC recommendation, n (%) | 34 (11.4) | 19 (11.2) | 13 (12.7) | 36 (12.5) |
Estimation of benefits and harms in TUE | ||||
Benefits are greater than harms, n (%) | 132 (44.4) | 79 (46.5) | 42 (41.2) | 123 (42.6) |
Benefits are almost equal to harms, n (%) | 83 (27.9) | 50 (29.4) | 27 (26.5) | 64 (22.1) |
Harms are greater than benefits, n (%) | 13 (4.4) | 7 (4.1) | 5 (4.9) | 14 (4.8) |
Unknown, n (%) | 66 (22.2) | 33 (19.4) | 26 (25.5) | 86 (29.8) |
Higher risk perception of delayed effect, n (%) | 93 (31.3)** | 56 (32.9) | 35 (34.3) | 138 (48.3)** |
Higher risk perception of genetic effect, n (%) | 63 (21.2)** | 38 (22.4) | 23 (22.5) | 106 (36.8)** |